Rekah Pharmaceutical Industry Ltd.Share · IL0010810096 (XTAE) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Rekah Pharmaceutical Industry Ltd.
No Price
Closing Price XTAE 01.05.2026:
1.136,00 ILA
01.05.2026 10:44
Current Prices from Rekah Pharmaceutical Industry Ltd.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
TASE
REKA.TA
ILA
01.05.2026 10:44
1.136,00 ILA
-14,00 ILA
-1,22 %
Share Float & Liquidity
Free Float16,46 %
Shares Float1,88 M
Shares Outstanding11,41 M
Company Profile for Rekah Pharmaceutical Industry Ltd. Share
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations. Its portfolio of products comprise approximately 280 drugs used in various medical fields. Rekah Pharmaceutical Industry Ltd. was founded in 1941 and is based in Holon, Israel.
